Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2021 16:05 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results

Company Reports Strong Cash Position as it Prepares to Initiate a CD34+ Cell Therapy Study in Diabetic Kidney Disease Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J.,...
October 28, 2021 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Host Third Quarter 2021 Financial Results Conference Call on Thursday, November 4th at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
October 04, 2021 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Announces Participation in Upcoming Conferences in October 2021

BASKING RIDGE, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
September 08, 2021 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BASKING RIDGE, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
September 01, 2021 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Announces Appointment of Kristen K. Buck, M.D., as Chief Medical Officer

BASKING RIDGE, N.J., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
August 05, 2021 16:05 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update

BASKING RIDGE, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
July 29, 2021 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., July 29, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
July 22, 2021 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Present at Zooming with LD

BASKING RIDGE, N.J., July 22, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
June 22, 2021 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Assess its CLBS201 CD34+ Cell Therapy in Diabetic Kidney Disease

BASKING RIDGE, N.J., June 22, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
June 17, 2021 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Present at Noble Capital Markets Virtual Investor Forum during the 16th Annual World Stem Cell Summit

BASKING RIDGE, N.J., June 17, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...